CHALKIS(000972)

Search documents
中基健康(000972) - 2018 Q2 - 季度财报
2018-08-24 16:00
Financial Performance - The company's operating revenue for the first half of 2018 was ¥336,010,975.33, representing a 90.95% increase compared to ¥175,970,904.72 in the same period last year[19]. - The net profit attributable to shareholders of the listed company was -¥83,846,141.90, compared to -¥40,068,245.37 in the previous year, indicating a significant loss[19]. - The net cash flow from operating activities increased by 109.01% to ¥67,745,581.37 from ¥32,412,535.80 year-on-year[19]. - The basic earnings per share were -¥0.1087, compared to -¥0.0520 in the same period last year[19]. - The weighted average return on net assets was -9.98%, a decrease of 5.04 percentage points compared to -4.94% in the previous year[19]. - The net profit attributable to shareholders was -¥83,846,141.90, worsening the loss by ¥43,777,896.53 year-on-year[31]. - The operating costs rose to ¥335,932,957.78, a 124.15% increase year-on-year, primarily due to increased sales volume of large-pack tomato sauce[35]. - The gross profit margin for the manufacturing sector decreased by 14.88% year-on-year, attributed to a prolonged market downturn and low sales prices[37]. - The net loss for the period was CNY 88,938,172.57, compared to a net loss of CNY 41,369,519.48 in the previous year, indicating a worsening financial performance[146]. Assets and Liabilities - Total assets decreased by 23.47% to ¥1,871,493,130.15 from ¥2,445,329,852.45 at the end of the previous year[19]. - The net assets attributable to shareholders of the listed company decreased by 10.46% to ¥790,100,529.02 from ¥882,362,014.79 at the end of the previous year[19]. - The company’s total assets and net assets are expected to significantly improve following the acquisition of Taihe Biochemical, enhancing profitability and asset quality[32]. - The total liabilities decreased from CNY 1,560,278,681.93 to CNY 1,088,130,653.22, showing a reduction in the company's debt levels[139]. - The total equity attributable to shareholders decreased from CNY 882,362,014.79 to CNY 790,100,529.02, indicating a decline in shareholder value[139]. Cash Flow - The company’s cash and cash equivalents decreased by ¥60,090,593.07, compared to a decrease of ¥14,487,464.32 in the previous year[35]. - The cash and cash equivalents at the end of the period amount to 63,658,051.30, down from 175,818,082.15 in the previous period, indicating a decrease of approximately 63.70%[153]. - The net cash flow from operating activities is 67,745,581.37, an increase from 32,412,535.80 in the previous period, showing a growth of about 108.67%[152]. - The total cash outflow from financing activities was 54,449,041.67, resulting in a net cash flow from financing activities of -34,449,041.67[156]. Strategic Plans and Acquisitions - The company plans to acquire 100% equity of Taihe Biochemical through a share issuance, aiming to enhance its dual main business structure in tomato and citric acid industries[32]. - The company plans to dispose of certain subsidiary equity to optimize resource allocation and improve asset structure[33]. - The company plans to continue optimizing its tomato product structure, focusing on the development and promotion of high-value-added tomato health products and beverages[58]. Legal and Compliance Issues - The company has faced risks related to weather conditions affecting tomato production and high market competition in the tomato sauce industry[56]. - The company has been involved in multiple legal disputes with MasterCard and Zhongchen Cans regarding contract violations and payment defaults[77]. - Zhongji Health has faced significant legal challenges, including multiple lawsuits related to contract breaches and financial obligations[80]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period is 46,298[119]. - The largest shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets Management Co., holds 15.46% of the shares[119]. - There were no changes in the controlling shareholder or actual controller during the reporting period[122]. Corporate Governance - The company has not engaged in any derivative investments or sold any significant assets or equity during the reporting period[49][50][51]. - The financial report for the half-year period was not audited[134]. - The integrity status of the company and its controlling shareholders is good, with no unfulfilled court judgments or significant overdue debts[91]. Operational Highlights - The company operates in the food processing industry, with a focus on health and medical technology investments[174]. - The company has established wastewater treatment facilities that meet discharge standards, with a treatment capacity of 450m3/H[108]. - The company has entered into a lease agreement for a total area of 60,000 square meters of land and 36,900 square meters of factory space for 8 years[102].
中基健康(000972) - 2018 Q1 - 季度财报
2018-04-27 16:00
Financial Performance - The company's revenue for Q1 2018 was ¥47,328,180.62, representing a decrease of 31.30% compared to ¥68,892,620.64 in the same period last year[8] - The net profit attributable to shareholders was -¥9,981,246.45, an improvement from -¥20,725,628.91 year-on-year[8] - The net cash flow from operating activities decreased by 61.35% to ¥6,407,367.83 from ¥16,578,893.39 in the previous year[8] - Operating revenue fell by 31.30% to ¥47,328,180.62, primarily due to a decline in sales volume of large-pack tomato sauce[16] - Operating costs decreased by 48.52% to ¥33,007,693.23, reflecting the drop in sales volume of large-pack tomato sauce[16] Assets and Shareholder Information - The total assets at the end of the reporting period were ¥2,337,542,096.39, down 4.41% from ¥2,445,329,852.45 at the end of the previous year[8] - The net assets attributable to shareholders decreased by 1.20% to ¥871,791,318.16 from ¥882,362,014.79 at the end of the previous year[8] - The total number of ordinary shareholders at the end of the reporting period was 47,386[11] - The largest shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets Management Co., held 15.46% of shares, totaling 119,243,804 shares[11] Cash Flow and Expenses - Cash and cash equivalents decreased by 42.71% to ¥70,896,003.65 due to repayment of loans and accounts payable[16] - Accounts payable decreased by 36.27% to ¥247,745,818.82 as a result of repayment of payables[16] - Financial expenses increased by 51.36% to ¥11,427,856.76, attributed to exchange rate fluctuations and increased borrowing costs[16] - Cash received from tax refunds rose by 39.53% to ¥13,171,869.85, driven by an increase in export tax rebates[16] - Cash paid for purchasing goods and services increased by 33.46% to ¥168,644,399.21 due to higher accounts payable payments[16] - Cash paid for debt repayment increased by 96.96% to ¥100,000,000.00, reflecting a rise in matured loans compared to the previous year[16] Non-Recurring Items and Strategic Changes - The company reported a total of ¥353,574.80 in non-recurring gains and losses during the reporting period[9] - There were no significant changes in the company's strategy or new product developments mentioned in the report[15] - The company did not report any significant events or changes in commitments during the reporting period[17][18] - There were no derivative investments during the reporting period[22] Return on Net Assets - The weighted average return on net assets improved to -1.14%, up by 1.38 percentage points from -2.52% year-on-year[8]
中基健康(000972) - 2017 Q4 - 年度财报
2018-03-22 16:00
Financial Performance - The company's operating revenue for 2017 was ¥517,710,604.78, a decrease of 11.98% compared to ¥588,176,013.79 in 2016[18]. - The net profit attributable to shareholders in 2017 was ¥36,689,853.12, a significant recovery from a loss of ¥254,111,462.52 in 2016[18]. - Basic earnings per share for 2017 were ¥0.05, compared to a loss of ¥0.33 per share in 2016[18]. - The total assets at the end of 2017 were ¥2,445,329,852.45, reflecting a 1.36% increase from ¥2,412,637,151.91 at the end of 2016[18]. - The net assets attributable to shareholders increased by 6.07% to ¥882,362,014.79 at the end of 2017, up from ¥831,844,874.38 in 2016[18]. - The weighted average return on net assets improved to 4.28% in 2017, a rise of 30.76 percentage points from -26.48% in 2016[18]. - The company achieved total revenue of ¥517,710,604.78, a decrease of 11.98% compared to ¥588,176,013.79 in the previous year[37]. - The net profit attributable to the parent company was ¥36,689,853.12, with net assets of ¥882,362,014.79[37]. - The manufacturing sector contributed ¥499,536,660.99, accounting for 96.49% of total revenue, down 12.36% from the previous year[43]. - The company reported a net profit for the 2017 fiscal year, reversing the negative net profit trend of the previous two years[92]. Cash Flow and Financial Management - The net cash flow from operating activities was -¥176,181,920.66, an improvement from -¥206,922,771.39 in the previous year[18]. - The company has faced challenges in cash flow management, as indicated by the negative cash flow from operating activities[18]. - The total cash inflow from financing activities increased by 35.93% to ¥1,029,000,000.00 in 2017, compared to ¥756,980,000.00 in 2016[57]. - The total amount of cash and cash equivalents decreased to ¥123,748,644.37, accounting for 5.06% of total assets, down from 9.24% in 2016[59]. - The company reported a net cash flow from operating activities of -¥176,181,920.66 in 2017, an improvement from -¥206,922,771.39 in 2016[57]. Market and Product Development - In Q1 2023, the company reported revenue of approximately ¥68.89 million, which increased to ¥517.71 million by Q4 2023, showing a significant growth trend[22]. - The company has established a seed company to control the source of tomato processing, aiming to improve the quality and yield of tomato varieties[31]. - The company has invested in 110 harvesting machines, which can reduce labor costs by 40%-60% compared to manual harvesting, enhancing efficiency and quality[32]. - The company’s "ChalkiS" brand tomato sauce has been recognized as a key product supported by the Ministry of Commerce, indicating strong market positioning[27]. - The company plans to enhance market marketing and cost management to improve the financial status of the tomato industry[28]. - The company aims to optimize its tomato product structure, focusing on the development and promotion of tomato health cosmetics and beverages, as well as high-value tomato lycopene health products[78]. Challenges and Risks - The company faced high production costs and weak profitability due to industry overcapacity and low international market prices[39]. - The company reported a 22.55% decrease in sales volume of bulk tomato sauce, with inventory levels increasing by 44%[47]. - The company faces risks related to weather conditions affecting tomato yield and quality, as well as high concentration in its tomato sauce product line and reliance on exports[79]. - The company has made efforts in business transformation, including raw material base construction and mechanical harvesting, but profitability remains low[75]. Governance and Compliance - The company continues to strengthen its governance structure by integrating party organization roles into its corporate governance framework[37]. - The company has not experienced any changes in the scope of consolidated financial statements compared to the previous year[90]. - The company has engaged Zhongxing Cai Guanghua Accounting Firm for audit services, with a fee of 1 million yuan for the current period[91]. - The company has not faced any penalties from securities regulatory agencies in the past three years[164]. - The company has maintained a complete and independent governance structure, ensuring no significant differences from regulatory requirements[173]. Shareholding and Ownership - The largest shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets Management Co., Ltd., holds 15.46% of the shares, totaling 119,243,804 shares[138]. - The second largest shareholder, Xinjiang Wujiaqu Urban Construction Investment Co., Ltd., holds 12.97% of the shares, totaling 100,000,000 shares[138]. - The company has no significant changes in shareholding structure or major events during the reporting period[131]. - The total number of shareholders at the end of the reporting period was 49,943, an increase from 48,545 at the previous month-end[138]. Social Responsibility and Community Engagement - The company is recognized as a key agricultural industrialization leading enterprise and has contributed significantly to the economic development of Xinjiang[124]. - The company has created over 4,000 long-term fixed employment opportunities and provided 8,000 seasonal job opportunities annually in rural areas[126]. - The company actively promotes energy conservation and environmental protection in its operations[125]. - The company is committed to integrating social responsibility with its development strategy and regularly evaluates its social responsibility practices[128].
中基健康(000972) - 2017 Q2 - 季度财报(更新)
2017-11-06 16:00
Financial Performance - The company's operating revenue for the first half of 2017 was ¥175,970,904.72, representing a 1.58% increase compared to ¥173,239,674.47 in the same period last year[19]. - The net profit attributable to shareholders was -¥40,068,245.37, an improvement from -¥54,720,007.25 in the previous year[19]. - The net cash flow from operating activities was ¥32,412,535.80, a significant recovery from -¥163,088,887.18 in the same period last year[19]. - The basic earnings per share improved to -¥0.0520 from -¥0.0709 in the same period last year[19]. - The weighted average return on net assets increased to -4.94%, up by 0.22 percentage points from -5.16% in the previous year[19]. - Operating costs decreased by 7.02% to ¥149,872,074.14, contributing to improved cost management[34]. - The gross profit margin for the manufacturing sector was 16.36%, an increase of 7.73% compared to the previous year[36]. - The company reported a significant increase in income tax expenses by 4,514.75% due to government subsidies being recognized as taxable income[34]. - The company reported a continuous net profit loss for the past two years, raising concerns about potential delisting risks if losses persist[56]. - The company reported a net profit loss of CNY 7,315,944.51 from its subsidiary Tianjin Zhongchen Tomato Products Co., Ltd., which had an operating income of CNY 45,550,814.45[52]. Assets and Liabilities - The total assets decreased by 10.28% to ¥2,164,727,299.71 from ¥2,412,637,151.91 at the end of the previous year[19]. - The net assets attributable to shareholders decreased by 4.55% to ¥793,959,459.01 from ¥831,844,874.38 at the end of the previous year[19]. - The company's cash and cash equivalents increased to ¥181,818,760.52, up from ¥109,640,709.67, representing a 3.63% increase in total asset proportion[39]. - The total current assets amounted to CNY 980,872,147.42, down from CNY 1,180,141,702.95, indicating a decline of approximately 16.91%[134]. - The total liabilities decreased to CNY 1,443,634,935.94 from CNY 1,652,358,098.66, a decline of approximately 12.61%[135]. - The total equity attributable to shareholders of the parent company was CNY 793,959,459.01, down from CNY 831,844,874.38, reflecting a decrease of about 4.55%[136]. - The company's total assets were CNY 2,164,727,299.71, down from CNY 2,412,637,151.91, indicating a decline of approximately 10.26%[136]. Corporate Governance and Compliance - The company plans not to distribute cash dividends or issue bonus shares for the year[6]. - There were no significant changes in the company's core business or major assets during the reporting period[25][26]. - The company has not engaged in derivative investments or sold significant assets or equity during the reporting period[48][49][50]. - The semi-annual report of the company was not audited[66]. - There were no bankruptcy reorganization matters during the reporting period[70]. - The company faced 65 civil lawsuits from investors due to false statements, with a total claim amount of approximately RMB 21,249,617.19[71]. - The court ruled to dismiss 23 investor lawsuits, involving a total amount of RMB 10,035,232.12[72]. - The company is involved in a lease contract dispute with Master Packaging Co., with claims for management fees, profit shares, and other compensations totaling RMB 67,877,894.95[74]. - The company has appealed against the first-instance judgment in the lease dispute case, which is currently under review by the Tianjin High People's Court[75]. - The company and its controlling shareholders have a good integrity status, with no significant overdue payments reported[82]. Strategic Initiatives - The company plans to establish a tomato industry fund with Xinjiang Kunlun Stone Equity Investment Management Co., Ltd. to invest in the tomato industry chain[32]. - A merger fund is being initiated with Hunan Jialian Asset Management Co., Ltd. to focus on investments and acquisitions in the health industry[32]. - The company aims to enhance its capital market financing and restructuring efforts to enter the high-growth health industry[59]. - The company plans to optimize its product structure by focusing on high-value tomato health drinks and lycopene health products[59]. - The company plans to strengthen its raw material base and improve cost efficiency across all stages of tomato production and processing[58]. Shareholder Information - The total number of shares remains at 771,283,579, with no changes during the reporting period[111]. - The largest shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets Management Co., holds 15.46% of shares, totaling 119,243,804 shares[115]. - Xinjiang Wujiaqu Urban Construction Investment Co., Ltd. holds 12.97% of shares, totaling 100,000,000 shares[115]. - Total number of common shareholders at the end of the reporting period is 56,224[115]. Environmental and Social Responsibility - The company employs over 4,000 long-term fixed job opportunities, contributing to local economic growth[102]. - The company has not reported any significant environmental protection issues during the reporting period[106]. - The company has not initiated any targeted poverty alleviation work during the reporting period and has no subsequent plans[100][105]. Financial Reporting and Accounting - The financial statements are prepared based on the assumption of going concern and comply with the relevant accounting standards[179]. - The company has no significant uncertainties affecting its ability to continue as a going concern within the next 12 months[180]. - The company follows the accrual basis of accounting, except for certain financial instruments[179]. - The accounting period for the company is based on the calendar year, from January 1 to December 31[182]. - The company uses Renminbi as its functional currency for accounting purposes[183].
中基健康(000972) - 2017 Q3 - 季度财报
2017-10-26 16:00
Financial Performance - Operating revenue for the reporting period was ¥191,611,687.47, representing a year-on-year increase of 38.44%[8] - Net profit attributable to shareholders of the listed company was ¥119,969,759.43, with a year-to-date increase of 17.95% to ¥367,582,592.19[8] - Basic earnings per share for the reporting period was ¥0.1556, compared to ¥0.1036 in the same period last year[8] - Net profit attributable to shareholders of the parent company reached ¥79,901,514.06, a 187.56% increase due to profitability this year[16] Assets and Liabilities - Total assets at the end of the reporting period reached ¥2,453,934,892.32, an increase of 1.71% compared to the previous year[8] - Net assets attributable to shareholders of the listed company increased by 9.76% to ¥913,058,348.44[8] - Cash and cash equivalents decreased by 40.26% to ¥133,235,643.14 due to various payments made during the period[16] - Deferred income tax liabilities increased by 71.05% to ¥1,052,819.18, resulting from changes in the value of available-for-sale financial assets[16] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 51,738[11] - The top shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets Management Co., Ltd., held 15.46% of shares[11] Operational Activities - The company reported a net cash flow from operating activities of -¥94,598,104.02 year-to-date[8] - Prepayments increased by 118.15% to ¥33,961,142.50, primarily for purchasing packaging materials during production[16] - Inventory rose by 39.38% to ¥893,820,284.49, attributed to the addition of new products[16] - Operating income from non-operating activities surged by 3,698.35% to ¥225,654,969.31, driven by increased debt waiver income[16] Financial Changes - Non-recurring gains and losses totaled ¥223,973,808.95, primarily from debt restructuring gains of ¥224,463,455.92[9] - The company reported a 676.74% increase in business tax and additional fees, totaling ¥4,725,829.24, due to changes in accounting[16] - Financial expenses rose by 47.84% to ¥28,444,190.63, mainly due to exchange rate fluctuations[16] - The company received cash from investments amounting to ¥1,024,180.57, marking a 100% increase as this business did not occur in the previous year[16] Commitments and Matters - The company has no significant matters or commitments that were not fulfilled during the reporting period[17][18]
中基健康(000972) - 2017 Q2 - 季度财报
2017-08-18 16:00
Financial Performance - The company's operating revenue for the first half of 2017 was ¥175,970,904.72, representing a 1.58% increase compared to ¥173,239,674.47 in the same period last year[19]. - The net profit attributable to shareholders was -¥40,068,245.37, an improvement from -¥54,720,007.25 in the previous year[19]. - The net cash flow from operating activities was ¥32,412,535.80, a significant recovery from -¥163,088,887.18 in the same period last year[19]. - The basic earnings per share for the first half of 2017 was -¥0.0520, an improvement from -¥0.0709 in the same period last year[19]. - The weighted average return on net assets was -4.94%, a slight increase of 0.22 percentage points from -5.16% in the previous year[19]. - Operating costs decreased by 7.02% to ¥149,872,074.14, contributing to improved cost management[34]. - The gross profit margin for the manufacturing sector was 16.36%, an increase of 7.73% compared to the previous year[36]. - The company reported a net profit loss of CNY 20,631,825.69 from its subsidiary Xinjiang Zhongji Red Tomato Industry Co., Ltd.[52]. - The net profit for the current period is CNY -41,369,519.48, an improvement from CNY -58,251,231.04 in the previous period, representing a reduction in loss of approximately 29.0%[144]. - The total comprehensive income for the current period is CNY -39,186,689.48, compared to CNY -59,285,719.04 in the previous period, indicating a significant improvement[144]. Assets and Liabilities - The total assets at the end of the reporting period were ¥2,164,727,299.71, down 10.28% from ¥2,412,637,151.91 at the end of the previous year[19]. - The net assets attributable to shareholders decreased by 4.55% to ¥793,959,459.01 from ¥831,844,874.38 at the end of the previous year[19]. - The company's total liabilities decreased to CNY 1,443,634,935.94 from CNY 1,652,358,098.66, showing a reduction of about 12.59%[135]. - The company's total non-current assets decreased to CNY 1,183,855,152.29 from CNY 1,232,495,448.96, indicating a decrease of about 3.95%[134]. - The company's total equity decreased to CNY 721,092,363.77 from CNY 760,279,053.25, reflecting a decline of approximately 5.15%[136]. - The company's cash and cash equivalents decreased from 223,025,602.47 RMB to 181,818,760.52 RMB, a decline of approximately 18.5%[133]. - Accounts receivable decreased from 183,234,415.05 RMB to 115,849,511.47 RMB, a decline of approximately 36.7%[133]. - Inventory decreased from 641,284,635.88 RMB to 592,570,592.94 RMB, a decline of approximately 7.6%[133]. - The total amount of retained earnings decreased by CNY 9,673,861.30 compared to the previous period[170]. Cash Flow - The operating cash flow net amount is CNY 32,412,535.80, a turnaround from CNY -163,088,887.18 in the previous period[150]. - The net cash flow from financing activities was -45,911,734.31 CNY, a decrease from -58,464,103.06 CNY in the previous period, indicating a reduction in cash outflow[151]. - The cash inflow from operating activities totaled 40,402,669.83 CNY, compared to 9,395,618.54 CNY in the previous period, showing a substantial increase[152]. - The cash outflow for purchasing goods and services was 1,763,602.78 CNY, down from 3,413,485.93 CNY in the previous period, indicating cost control measures[152]. Business Operations - The company plans to establish a tomato industry fund with Xinjiang Kunlun Stone Investment Management Co., Ltd. to invest in the tomato industry chain[32]. - A merger fund is being initiated with Hunan Jialian Asset Management Co., Ltd. to focus on investments and acquisitions in the health industry[32]. - The company plans to enhance its tomato product structure by developing and promoting high-value tomato health drinks and lycopene health products[59]. - The company aims to reduce costs and improve efficiency across all stages of its tomato production and processing operations[58]. - The company operates in the food processing industry, with business activities including investment in health and medical technology industries, project investment, and asset management consulting[176]. Legal and Compliance Issues - The company faced 65 civil lawsuits from investors due to false statements, with a total claim amount of approximately RMB 21,249,617.19[71]. - The court ruled to dismiss 23 investor lawsuits, involving a total amount of RMB 10,035,232.12[71]. - The company is involved in a lease contract dispute with Master Packaging, claiming a total compensation of RMB 67,877,894.95[74]. - The company has appealed against the first-instance judgment regarding the lease contract dispute, and the case is currently under review by the Tianjin High Court[75]. - The company has not reported any major environmental issues or significant matters requiring explanation during the reporting period[106][107]. Corporate Governance - The company has not distributed cash dividends or increased share capital during the reporting period[64]. - There were no significant guarantees provided by the company to external parties during the reporting period[95]. - The company approved a total guarantee amount of CNY 70 million during the reporting period, with an actual guarantee amount of CNY 10 million[97]. - The company and its controlling shareholders have a good integrity status, with no significant overdue payments reported[82]. - The company has not engaged in any significant related party transactions during the reporting period[84]. Future Outlook - The company anticipates a continued net profit loss for the year, which may lead to a risk of delisting if the negative trend persists[55]. - The company has faced risks related to weather conditions affecting tomato production and a high concentration in its product offerings[56]. - The company has not initiated any targeted poverty alleviation work during the reporting period and has no subsequent plans[100][105].
中基健康(000972) - 2017 Q1 - 季度财报
2017-04-28 16:00
Financial Performance - The company's revenue for Q1 2017 was ¥68,892,620.64, a decrease of 38.53% compared to ¥112,072,369.04 in the same period last year[8] - The net profit attributable to shareholders was -¥20,725,628.91, an improvement from -¥22,442,614.68 year-on-year[8] - The net cash flow from operating activities was ¥16,578,893.39, a significant recovery from -¥210,993,620.99 in the previous year[8] - Revenue declined by 38.53% to ¥68,892,620.64, primarily due to a significant drop in sales volume of small packaged products[16] Assets and Liabilities - The total assets at the end of the reporting period were ¥2,239,574,886.38, down 7.17% from ¥2,412,637,151.91 at the end of the previous year[8] - The net assets attributable to shareholders decreased by 2.27% to ¥812,977,101.47 from ¥831,844,874.38 at the end of the previous year[8] - Accounts receivable decreased by 37.43% to ¥114,646,905.96 due to increased collection efforts[16] - Prepayments decreased by 65.89% to ¥19,433,744.73 as products were sold, reducing advance payments[16] - Cash paid for purchasing goods and services decreased by 59.12% to ¥126,359,190.32 due to a reduction in accounts payable[16] - Cash paid for debt repayment increased by 396.18% to ¥50,772,800.00, reflecting repayment of bank loans[16] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 63,507[10] - The largest shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets Management Co., Ltd., held 15.46% of the shares[11] - There were no preferred shareholders during the reporting period[13] Operational Efficiency - The weighted average return on net assets improved by 0.23 percentage points to -2.52% from -2.75% year-on-year[8] - Management expenses reduced by 39.79% to ¥11,160,810.27, attributed to lower salary and depreciation expenses[16] Government Support and Events - The company received government subsidies amounting to ¥121,739.73 during the reporting period[9] - The company reported no significant events during the reporting period[17] - There were no violations of external guarantees or non-operating fund occupation by controlling shareholders[25][26] Other Comprehensive Income - Other comprehensive income fell by 100.62% to ¥3,704,353.54 due to a decline in stock prices[16] - Cash received from loans was zero, indicating no new loans were obtained during the period[16]
中基健康(000972) - 2016 Q4 - 年度财报
2017-04-14 16:00
Financial Performance - The company reported consecutive net losses for 2015 and 2016, leading to a "delisting risk warning" from the Shenzhen Stock Exchange[6]. - The company plans to not distribute cash dividends or issue bonus shares for the year[6]. - The company's operating revenue for 2016 was ¥588,176,013.79, a decrease of 13.87% compared to ¥682,896,707.47 in 2015[18]. - The net profit attributable to shareholders for 2016 was -¥254,111,462.52, compared to -¥48,308,582.78 in 2015, indicating a significant loss[18]. - The net cash flow from operating activities for 2016 was -¥206,922,771.39, worsening from -¥38,448,076.69 in 2015[18]. - The total assets at the end of 2016 were ¥2,412,637,151.91, down 8.26% from ¥2,629,834,559.20 at the end of 2015[19]. - The net assets attributable to shareholders decreased by 23.51% to ¥831,737,536.97 in 2016 from ¥1,087,440,444.08 in 2015[19]. - The company reported a weighted average return on equity of -26.48% in 2016, a decline of 10.97 percentage points from -15.51% in 2015[18]. - The company’s stock will face suspension if the net profit or net assets remain negative for the fiscal year 2017[6]. - The company reported a net profit of -26,867.22 million, with a net profit attributable to shareholders of -25,411.15 million, indicating a significant loss[103]. Business Strategy and Operations - The company aims to leverage the "Belt and Road" and "Healthy China" national strategies to transform and upgrade its operations[16]. - The company is focusing on capital operations and mergers and acquisitions to enhance its market position in the health industry[16]. - The company aims to continue consolidating and developing its "red industry" while exploring the health industry for future growth[30]. - The company is focusing on developing high-value-added tomato products, including health drinks and lycopene health products[90]. - The company plans to enhance its raw material base and mechanization in tomato planting and harvesting to reduce costs and improve efficiency[89]. - The company is pursuing mergers and acquisitions to expand its business in the health industry and create new profit growth points[90]. - The company is exploring potential mergers and acquisitions to enhance its product offerings and market reach[182]. - The company has a strategic plan to increase shareholder value through potential mergers and acquisitions in the health industry[173]. Challenges and Risks - The company faced severe challenges including overcapacity in the domestic tomato sauce industry and low international market prices, leading to significant operational pressure[38]. - The tomato supply instability due to factors like planting area and climate has led to underutilization of production capacity[86]. - The company is facing challenges in upgrading its main business due to a lack of high-quality tomato varieties and advanced planting technology[86]. - The long-term outlook for the tomato sauce industry remains pessimistic, with low added value and limited market capacity posing significant challenges[87]. - The company has experienced consecutive years of negative net profit for 2015 and 2016, risking delisting if it does not achieve positive results in 2017[92]. Corporate Governance and Compliance - The company has engaged Zhongxing Caiguanghua Accounting Firm to audit its financial reports, which received an unqualified opinion with emphasis on certain matters[5]. - The company has not changed its accounting policies, estimates, or methods during the reporting period[111]. - The company has not experienced any significant accounting errors requiring restatement during the reporting period[112]. - The integrity status of the company and its controlling shareholders is good, with no unfulfilled court judgments or significant overdue debts[127]. - The company has established a comprehensive corporate governance structure in compliance with relevant laws and regulations, ensuring no significant discrepancies with the requirements set by the China Securities Regulatory Commission[198]. Human Resources and Employment - The company employed a total of 1,123 staff, with 455 in production, 32 in sales, and 274 in technical roles[191]. - The total remuneration for directors, supervisors, and senior management in 2016 amounted to 1.8672 million yuan (including tax) for 21 individuals[188]. - The company has established a transparent performance evaluation and incentive mechanism for employee remuneration[193]. - The company has no labor outsourcing situations reported during the period[195]. - The company has created over 4,000 long-term fixed employment opportunities and provides 8,000 seasonal job opportunities annually in rural areas of Xinjiang, Inner Mongolia, and Gansu[146]. Environmental and Social Responsibility - The company emphasizes energy conservation and environmental protection, implementing policies to improve energy utilization and wastewater treatment capabilities[145]. - The company has established a comprehensive environmental protection policy tailored to the seasonal production of tomato sauce[145]. - The company actively supports poverty alleviation by donating goods and providing assistance to families in need[147]. - The company has helped over 200,000 local farmers increase their income through tomato cultivation, contributing to regional economic growth[146]. Market and Product Development - The company is focusing on expanding its market presence and enhancing its product offerings through new technology development[173]. - The company plans to enhance its digital marketing efforts to attract a younger demographic, aiming for a 20% increase in engagement[182]. - New product launches are expected to contribute an additional 300 million RMB in revenue, with a focus on health-related technologies[182]. - Investment in research and development has increased by 30%, focusing on innovative health solutions[182]. Financial Position and Capital Management - The company requires approximately 800 million RMB in working capital for its 2017 operations, facing significant financial pressure[90]. - The company has not engaged in any major contracts that generated profits exceeding 10% of the total profit for the reporting period[134]. - The company has not engaged in any entrusted financial management or loans during the reporting period[141][142]. - The company has not issued any social responsibility reports during the reporting period[148].
中基健康(000972) - 2016 Q3 - 季度财报
2016-10-28 16:00
Financial Performance - Operating revenue for the reporting period was ¥138,407,183.03, down 4.39% year-on-year, and total revenue for the year-to-date was ¥311,646,857.50, a decrease of 21.04%[8] - The net profit attributable to shareholders of the listed company was a loss of ¥36,535,006.88 for the reporting period, with a year-to-date loss of ¥91,255,014.13[8] - Basic and diluted earnings per share were both -¥0.0474 for the reporting period[8] - The weighted average return on net assets was -3.60%, an increase of 1.41 percentage points compared to the previous year[8] - The company does not anticipate significant changes in net profit for the fiscal year compared to the previous year[28] Assets and Liabilities - Total assets at the end of the reporting period reached ¥2,667,952,923.79, an increase of 1.45% compared to the previous year-end[8] - Net assets attributable to shareholders of the listed company decreased by 8.47% to ¥995,386,189.95[8] - Cash and cash equivalents decreased by 58.33% to ¥139,575,998.03 due to payments for outstanding raw material costs[17] - Inventory increased by 53.71% to ¥902,873,709.27 as timely payments for raw materials were made during the production period[17] - Prepayments rose by 149.52% to ¥39,114,922.54, primarily for packaging materials[17] Cash Flow - The company reported a net cash flow from operating activities of -¥262,633,653.82 year-to-date[8] - Cash received from operating activities decreased by 53.33% to ¥51,914,789.67, primarily due to a reduction in receivables[18] - Cash paid for purchasing goods and services increased by 31.07% to ¥525,180,250.62, reflecting higher procurement costs[18] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 66,002[11] - The largest shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets Management Co., Ltd., held 15.46% of shares, totaling 119,243,804 shares[12] Legal Matters - The company is involved in ongoing litigation related to investor claims, with a total claim amount of approximately ¥21,249,617.19[19] - The company has incurred a direct economic loss of CNY 6,183,333.33 due to a contract violation by Mastercard, resulting in a 7-month delay in receiving goods[25] - As of the report date, the lawsuit against Mastercard has not progressed, with the company having filed a request with the Tianjin Second Intermediate People's Court[25] - The company has received multiple announcements regarding litigation matters, including updates on investor lawsuits as of August 4, August 20, and September 27, 2016[26] Operational Insights - Management expenses increased by 46.18% to ¥50,484,844.56 due to changes in consolidation scope and increased employee count[17] - Financial expenses rose by 42.13% to ¥19,239,579.95, mainly due to exchange rate fluctuations[17] - The company received a total of ¥166,980,000.00 in borrowings, a decrease of 42.54% compared to the previous period[18] - The company holds 301,600 shares of Beixin Road and Bridge, with a book value of CNY 2,602,808 and a loss of CNY 799,240 during the reporting period[28] - There were no derivative investments during the reporting period[29] - The company received over 150 phone inquiries and responded to more than 90 written inquiries from investors regarding production operations and major asset restructuring[30] - There were no instances of non-compliant external guarantees during the reporting period[31] - The company reported no non-operating fund occupation by controlling shareholders or related parties[32]
中基健康(000972) - 2016 Q2 - 季度财报
2016-07-29 16:00
Financial Performance - The company's operating revenue for the first half of 2016 was ¥173,239,674.47, a decrease of 30.69% compared to ¥249,952,477.09 in the same period last year[24]. - The net profit attributable to shareholders of the listed company was -¥54,720,007.25, worsening from -¥25,362,620.11 in the previous year[24]. - The net cash flow from operating activities was -¥163,088,887.18, a significant decline of 1,516.01% compared to ¥11,517,471.50 in the same period last year[24]. - The basic earnings per share were -¥0.0709, compared to -¥0.0329 in the previous year[24]. - The total assets at the end of the reporting period were ¥2,298,921,255.84, down 12.58% from ¥2,629,834,559.20 at the end of the previous year[24]. - The net assets attributable to shareholders of the listed company decreased by 5.13%, amounting to ¥1,031,685,948.83 compared to ¥1,087,440,444.08 at the end of the previous year[24]. - The weighted average return on net assets was -5.16%, a decrease of 2.05 percentage points from -3.11% in the previous year[24]. - The company reported a net loss of CNY 902,416,108.92, compared to a loss of CNY 847,696,101.67 in the previous period[128]. - Comprehensive income totalled -¥59,285,719.04, worsening from -¥30,244,715.52 year-over-year[136]. Business Strategy and Operations - The company has undergone a name change from "Xinjiang Zhongji Industrial Co., Ltd." to "Zhongji Health Industry Co., Ltd." during the reporting period[20]. - The company has expanded its business scope to include investments in various health-related sectors, including pharmaceuticals and health management services[21]. - The company has initiated a major asset restructuring to transition towards a health industry strategy, aiming for comprehensive operational development through mergers and acquisitions[31]. - The company aims to maintain a development path combining asset management and capital operations, viewing mergers and acquisitions as a key future growth strategy[32]. - The company has established a joint venture, Xinjiang Zhongji Tianren Biological Technology Co., with a registered capital of ¥100 million, in which it holds a 51% stake[42]. - The company has signed a lease agreement for a total area of 60,000 square meters of land and 36,900 square meters of factory buildings for 8 years[86]. Financial Management and Governance - The company plans not to distribute cash dividends or issue bonus shares[6]. - The company’s governance structure complies with relevant laws and regulations, ensuring proper operation of the board and shareholder meetings[63]. - The company has not predicted significant changes in net profit compared to the previous year for the reporting period[55]. - The company received over 120 investor inquiries regarding production operations and major asset restructuring during the reporting period[60]. - The company has no violations regarding external guarantees during the reporting period[91]. - The company has not faced any penalties or rectification issues during the reporting period[96]. - The company has been involved in planning significant matters, including major asset restructuring, with multiple announcements made regarding the status of these plans[98]. Shareholder Information - The total number of shares remained unchanged at 771,283,579, with no new shares issued during the reporting period[108]. - The total number of ordinary shareholders at the end of the reporting period was 68,877[111]. - The largest shareholder, Xinjiang Production and Construction Corps, held 15.46% of the shares, amounting to 119,243,804 shares[111]. - The company reported no changes in asset and liability structure during the reporting period[109]. - The total number of shares held by directors, supervisors, and senior management increased by 162,500 shares during the reporting period[119]. Cash Flow and Liquidity - The company reported a significant cash decrease of 267.50%, with a net increase in cash and cash equivalents of -¥225,332,662.01[36]. - Cash and cash equivalents decreased significantly from CNY 334,973,371.68 to CNY 109,640,709.67, a drop of about 67.3%[125]. - The total cash inflow from operating activities was 9,395,618.54, down from 19,163,531.29 in the previous period, reflecting a decline in operational revenue[145]. - The cash flow from financing activities included 138,600,000.00 from borrowings, indicating reliance on debt financing[146]. Legal and Compliance Issues - The company faced 65 civil lawsuits from investors with a total claim amount of approximately RMB 21.25 million due to alleged false statements[70]. - Tianjin Zhongchen was ordered to pay compensation to Kangjia Food (Mauritius) Co., Ltd. based on the assessed value of the property rights and land use rights due to failure to transfer within 90 days[65]. - The company has not engaged in entrusted financial management, derivative investments, or entrusted loans during the reporting period[47][48][49]. Accounting Policies and Financial Reporting - The financial statements are prepared in Renminbi (RMB) with the unit being Yuan[124]. - The financial report reflects the company's financial position, operating results, and cash flows as of June 30, 2016, in accordance with the relevant accounting standards[172]. - The company follows the accrual basis of accounting for its financial reporting[169]. - The company has not reported any changes in accounting policies or prior period error corrections during the current period[155].